» Articles » PMID: 34409084

Post-translational Acetylation Control of Cardiac Energy Metabolism

Overview
Date 2021 Aug 19
PMID 34409084
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Perturbations in myocardial energy substrate metabolism are key contributors to the pathogenesis of heart diseases. However, the underlying causes of these metabolic alterations remain poorly understood. Recently, post-translational acetylation-mediated modification of metabolic enzymes has emerged as one of the important regulatory mechanisms for these metabolic changes. Nevertheless, despite the growing reports of a large number of acetylated cardiac mitochondrial proteins involved in energy metabolism, the functional consequences of these acetylation changes and how they correlate to metabolic alterations and myocardial dysfunction are not clearly defined. This review summarizes the evidence for a role of cardiac mitochondrial protein acetylation in altering the function of major metabolic enzymes and myocardial energy metabolism in various cardiovascular disease conditions.

Citing Articles

Mitochondrial lysine acylation and cardiometabolic stress: Truth or consequence?.

Muoio D, Williams A, Grimsrud P Curr Opin Physiol. 2024; 27.

PMID: 39606008 PMC: 11601992. DOI: 10.1016/j.cophys.2022.100551.


Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond.

Sun Q, Karwi Q, Wong N, Lopaschuk G Cardiovasc Res. 2024; 120(16):1996-2016.

PMID: 39453987 PMC: 11646102. DOI: 10.1093/cvr/cvae231.


The role of acetylation in obesity-induced cardiac metabolic alterations.

Ketema E, Lopaschuk G J Pharm Pharm Sci. 2024; 27:13080.

PMID: 39109269 PMC: 11300292. DOI: 10.3389/jpps.2024.13080.


Proteome-wide Characterization and Pathophysiology Correlation in Non-ischemic Cardiomyopathies.

Lee S, Jang D, Kyoung Y, Kim J, Kim E, Hwang I Korean Circ J. 2024; 54(8):468-481.

PMID: 38956938 PMC: 11306425. DOI: 10.4070/kcj.2024.0033.


Protein lysine acetylation does not contribute to the high rates of fatty acid oxidation seen in the post-ischemic heart.

Ketema E, Ahsan M, Zhang L, Karwi Q, Lopaschuk G Sci Rep. 2024; 14(1):1193.

PMID: 38216627 PMC: 10786925. DOI: 10.1038/s41598-024-51571-0.


References
1.
Purushotham A, Schug T, Xu Q, Surapureddi S, Guo X, Li X . Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009; 9(4):327-38. PMC: 2668535. DOI: 10.1016/j.cmet.2009.02.006. View

2.
Chalkiadaki A, Guarente L . High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab. 2012; 16(2):180-8. PMC: 3539750. DOI: 10.1016/j.cmet.2012.07.003. View

3.
Sundaresan N, Pillai V, Wolfgeher D, Samant S, Vasudevan P, Parekh V . The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal. 2011; 4(182):ra46. DOI: 10.1126/scisignal.2001465. View

4.
Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L . The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012; 483(7388):218-21. DOI: 10.1038/nature10815. View

5.
Di Lisa F, Bernardi P . A CaPful of mechanisms regulating the mitochondrial permeability transition. J Mol Cell Cardiol. 2009; 46(6):775-80. DOI: 10.1016/j.yjmcc.2009.03.006. View